Patents by Inventor Jurgen Blumbach

Jurgen Blumbach has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6159988
    Abstract: Compounds of formula I, ##STR1## and the physiologically tolerable salts thereof, wherein the substituents R.sub.1 -R.sub.4 have the meanings given in the specifications and show an activity against inflammatory conditions.
    Type: Grant
    Filed: June 29, 1998
    Date of Patent: December 12, 2000
    Assignee: Hoeschst Aktiengesellschaft
    Inventors: Ramachandra Ganapati Naik, Vilas Narayan Mumbaikar, Ravishankar Vasumathy, Aftab Dawoodbhai Lakdawala, Mandakini Bipin Alreja, Bansi Lal, Jurgen Blumbach, Klaus Ulrich Weithmann, Robert Ryder Bartlett, Kalpana Sanjay Joshi, Swati Bal-Tembe, Sadagopan Raghavan
  • Patent number: 5869523
    Abstract: Process for the preparation of 6-(substitutedaminopropionyl)-derivatives of forskolinProcess for the manufacture of 6.beta.
    Type: Grant
    Filed: July 22, 1991
    Date of Patent: February 9, 1999
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Noel John de Souza, Adolf D'Sa, Samba Laxminarayan Kattige, Gulab Bajirao Padwal, Jurgen Blumbach
  • Patent number: 5821252
    Abstract: Compounds of the formula III ##STR1## in which R.sub.4 and R.sub.5 are CH.sub.3 amd R.sub.6 is hydrogen, have prolonged spasmolytic and anaesthetic activity.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: October 13, 1998
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Swati Bal-Tembe, Jurgen Blumbach, Alihussein Nomanbhai Dohadwalla, deceased, Bansi Lal, Narayan Sudhindra Punekar, Ramanujam Rajgopalan, Richard Helmut Rupp, Martin Bickel
  • Patent number: 5776977
    Abstract: Compounds of formula I, ##STR1## wherein the substituents R.sub.1 -R.sub.4 and a have the given meanings and show an activity against inflammatory conditions.
    Type: Grant
    Filed: August 5, 1996
    Date of Patent: July 7, 1998
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Ramachandra Ganapati Naik, Vilas Narayan Mumbaikar, Rangarajan Vasumathy, Aftab Dawoodbhai Lakdawala, Mandakini Vithalrao Shirole, Bansi Lal, Jurgen Blumbach, Klaus Ulrich Weithmann, Robert Ryder Bartlett
  • Patent number: 5589514
    Abstract: Compounds of formula I, ##STR1## wherein the substituents R.sub.1 -R.sub.4 and a have the given meanings and show an activity against inflammatory conditions.
    Type: Grant
    Filed: May 19, 1995
    Date of Patent: December 31, 1996
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Ramachandra G. Naik, Vilas N. Mumbaikar, Rangarajan Vasumathy, Aftab D. Lakdawala, Mandakini V. Shirole, Bansi Lal, Jurgen Blumbach, Klaus U. Weithmann, Robert R. Bartlett
  • Patent number: 5571701
    Abstract: Balhimycin, a compound of the molecular formula C.sub.66 H.sub.73 C1.sub.2 N.sub.9 0.sub.
    Type: Grant
    Filed: May 24, 1995
    Date of Patent: November 5, 1996
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Suresh R. Nadkarni, Sugata Chatterjee, Mahesh V. Patel, Kalvanapuram R. Desikan, Erra K. S. Vijayakumar, Bimal N. Ganguli, Jurgen Blumbach, Hans-Wolfram Fehlhaber, Herbert Kogler
  • Patent number: 5451570
    Abstract: Balhimycin, a compound of the molecular formula C.sub.66 H.sub.73 Cl.sub.2 N.sub.9 O.sub.24, is a novel Glycopeptide antibiotic and has the following structure (SEQ. ID. No.
    Type: Grant
    Filed: December 30, 1992
    Date of Patent: September 19, 1995
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Suresh R. Nadkarni, Sugata Chatterjee, Mahesh V. Patel, Kalvanapuram R. Desikan, Erra K. S. Vijayakumar, Bimal N. Ganguli, Jurgen Blumbach, Hans-Wolfram Fehlhaber, Herbert Kogler
  • Patent number: 5292751
    Abstract: The present invention relates to 5,7-Dihydroxy-2-methyl-8-[4-(3-hydroxy-1-(1-propyl))piperidinyl]-4H-1-benz opyran-4-one its preparation and its use.5,7-Dihydroxy-2-methyl-8-[4-(3-hydroxy-1-(1-propyl))piperidinyl]-4H-1-benzo pyran-4-one is useful for the treatment of arthritis and/or rheumatism and for the treatment of chronic inflammatory diseases.
    Type: Grant
    Filed: April 8, 1992
    Date of Patent: March 8, 1994
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Ramachandra G. Naik, Shrikant V. Rao, Aftab D. Lakdawala, Mandakini V. Shirole, Bansi Lal, Noel J. de Souza, Jurgen Blumbach
  • Patent number: 5270182
    Abstract: The novel compounds of formulas I and II ##STR1## have an antibiotic activity.
    Type: Grant
    Filed: May 7, 1992
    Date of Patent: December 14, 1993
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Christopher M. M. Franco, Dilip J. Upadhyay, Louis E. L. Coutinho, Bimal N. Ganguli, Jurgen Blumbach, Hans-Wolfram Fehlhaber, Herbert Kogler
  • Patent number: 5268471
    Abstract: Process for the preparation of 6-acyl-, 7-acyl- or 6,7-diacyl analogues of forskolin of the general formula ##STR1##
    Type: Grant
    Filed: January 15, 1993
    Date of Patent: December 7, 1993
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Noel J. de Souza, Premanand D. Desai, Shrikant V. Savanur, Jurgen Blumbach
  • Patent number: 5250682
    Abstract: Process for the manufacture of 6.beta.
    Type: Grant
    Filed: July 22, 1991
    Date of Patent: October 5, 1993
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Yatendra Khandelwal, Bansi Lal, Jurgen Blumbach
  • Patent number: 5246930
    Abstract: Compounds of formula I ##STR1## in which the substituted R has the given meaning, have an antimalarial and a antiviral activity.
    Type: Grant
    Filed: May 3, 1991
    Date of Patent: September 21, 1993
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Bindumadhavan Venugopalan, Chintamani P. Bapat, Pravin J. Karnik, Bansi Lal, Dipak K. Chatterjee, Subramani N. Iyer, Jurgen Blumbach
  • Patent number: 5162368
    Abstract: Butalactin, a compound of the formula I ##STR1## can be produced by cultivation of Streptomyces species Y-86,36923. Butalactin has an antibiotic activity.
    Type: Grant
    Filed: August 6, 1990
    Date of Patent: November 10, 1992
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Christopher M. M. Franco, Erra K. Vijayakumar, Sugata Chatterjee, Bimal N. Ganguli, Jurgen Blumbach
  • Patent number: 5141942
    Abstract: Pharmaceutical compositions comprising labdane diterpenoid derivatives and pyrimido(6,1-a)-isoquinolin-4-one derivatives when administered to the skin of a mammal or of the man increase the rate of terminal hair growth, stimulate the conversion of vellus hair to growth as terminal hair and arrest hair loss. They can be used for the treatment of several kinds of alopecia.
    Type: Grant
    Filed: November 17, 1989
    Date of Patent: August 25, 1992
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Bansi Lal, Jurgen Blumbach, Alihussein N. Dohadwalla, Noel J. de Souza
  • Patent number: 5114967
    Abstract: Alisamycin, a compound of the formula I ##STR1## has an antibiotic, antitumor and antiparasitic action.
    Type: Grant
    Filed: January 10, 1991
    Date of Patent: May 19, 1992
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Christopher M. M. Franco, Erra K. S. Vijayakumar, Sugata Chatterjee, Bimal N. Ganguli, Jurgen Blumbach, Herbert Kogler, Hans-Wolfram Fehlhaber
  • Patent number: 5100887
    Abstract: Cephemcarboxylic acid esters of the general formula ##STR1## pharmaceutical preparations which are active against bacterial infections, which contain such cephem derivatives, a process for the preparation of the cephem derivatives and the pharmaceutical preparations, and also the use of the cephem derivatives for combating bacterial infections.
    Type: Grant
    Filed: July 23, 1990
    Date of Patent: March 31, 1992
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Friedhelm Adam, Jurgen Blumbach, Walter Durckheimer, Gerd Fischer, Burghard Mencke, Dieter Isert, Gerhard Seibert
  • Patent number: 5071979
    Abstract: What are disclosed are anti-bacterially active cephalosporin compounds of the formula ##STR1## pharmaceutical preparations containing such compounds, methods of making the compounds, methods for combatting bacterial infections therewith, and intermediates for such compounds.
    Type: Grant
    Filed: May 10, 1982
    Date of Patent: December 10, 1991
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Rudolf Lattrell, Manfred Wieduwilt, Walter Durckheimer, Jurgen Blumbach, Karl Seeger
  • Patent number: 4762848
    Abstract: Heterocyclic sulfides of the general formula heterocycle-S-R, a process for their preparation and, in particular, their use for immunostimulation, immunorestoration and cytostatic treatment, and pharmaceutical agents, which contain a sulfide of this type, for these indications.
    Type: Grant
    Filed: March 10, 1986
    Date of Patent: August 9, 1988
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Karl-Heinz Scheunemann, Walter Durckheimer, Jurgen Blumbach, Michael Limbert, Hans-Ulrich Schorlemmer, Gerhard Dickneite, Hans-Harald Sedlacek
  • Patent number: 4603129
    Abstract: What are disclosed are cephalosporin compounds of the formula ##STR1## pharmaceutical preparations which are active against bacterial infections and in which these cephem compounds are present, process for the preparation of the cephem compounds and of the pharmaceutical preparations, use of the cephem compounds for combating bacterial infections, and compounds used as starting materials in the synthesis of said cephem compounds.
    Type: Grant
    Filed: December 19, 1983
    Date of Patent: July 29, 1986
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Jurgen Blumbach, Walter Durckheimer, Karl Seeger
  • Patent number: RE34865
    Abstract: Cephemcarboxylic acid esters of the general formula ##STR1## pharmaceutical preparations which are active against bacterial infections, which contain such cephem derivatives, a process for the preparation of the cephem derivatives and the pharmaceutical preparations, and also the use of the cephem derivatives for combating bacterial infections.
    Type: Grant
    Filed: November 19, 1992
    Date of Patent: February 21, 1995
    Assignee: Hoechst Aktiengesellschaft
    Inventors: Friedhelm Adam, Jurgen Blumbach, Walter Durckheimer, Gerd Fischer, Burghard Mencke, Dieter Isert, Gerhard Seibert